Limitations and possibilities of low cell number ChIP-seq

Gregor D Gilfillan1, Timothy Hughes, Ying Sheng

  • 1Department of Medical Genetics, Oslo University Hospital, Norway. gregor.gilfillan@medisin.uio.no

BMC Genomics
|November 23, 2012
PubMed
Summary

This study presents an optimized native chromatin immunoprecipitation coupled with high-throughput DNA sequencing (ChIP-seq) protocol that significantly reduces cell input requirements. The enhanced method allows for epigenetic analysis using rare or primary cells, overcoming previous limitations.